Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ResMed
RMD
|
+$487M |
| 2 |
Mettler-Toledo International
MTD
|
+$445M |
| 3 |
Copart
CPRT
|
+$409M |
| 4 |
Johnson Controls International
JCI
|
+$364M |
| 5 |
Phillips 66
PSX
|
+$318M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$928M |
| 2 |
Microsoft
MSFT
|
+$910M |
| 3 |
Apple
AAPL
|
+$816M |
| 4 |
Walt Disney
DIS
|
+$687M |
| 5 |
Amazon
AMZN
|
+$484M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.99% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIMX
3926
Himax Technologies
HIMX
$2.56B
| $80.1K | ﹤0.01% |
14,971
+19
| +0.1% | +$109 |
|
|
OCEA
3927
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $79.9K | ﹤0.01% |
21,117
+1,588
| +8% | +$2.98K |
|
|
VAXX
3928
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $78.9K | ﹤0.01% |
110,015
-10,650
| -9% | -$7.72K |
|
3929
Envela
ELA
$420M
| $77.6K | ﹤0.01% |
16,806
-656
| -4% | -$2.91K |
|
3930
American Resources Corp
AREC
$302M
| $75.3K | ﹤0.01% |
53,423
-21,110
| -28% | -$31.2K |
|
|
DZSI
3931
DELISTED
DZS Inc. Common Stock
DZSI
| $75.1K | ﹤0.01% |
56,906
-6,476
| -10% | -$9.79K |
|
3932
TransAlta
TAC
$3.99B
| $74.2K | ﹤0.01% |
11,542
+309
| +3% | +$2.19K |
|
|
HYPD
3933
Hyperion DeFi Inc
HYPD
$42.9M
| $73.6K | ﹤0.01% |
933
-18
| -2% | -$2.45K |
|
3934
Wipro
WIT
$19.4B
| $72.3K | ﹤0.01% |
25,164
+3,386
| +16% | +$9.99K |
|
3935
Protara Therapeutics
TARA
$233M
| $71.8K | ﹤0.01% |
17,907
| – | – |
|
3936
Core Scientific
CORZ
$6.36B
| $71.5K | ﹤0.01% |
+20,205
| New | +$70.1K |
|
|
STLN
3937
Starling Oncology, Inc. Common Stock
STLN
$638M
| $71.2K | ﹤0.01% |
45,068
-3,651
| -7% | -$6.94K |
|
3938
BlackBerry
BB
$5.27B
| $71.1K | ﹤0.01% |
25,776
| – | – |
|
|
3939
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.29B
| $68.1K | ﹤0.01% |
+51,169
| New | +$76K |
|
3940
First Majestic Silver
AG
$9.26B
| $66.5K | ﹤0.01% |
11,307
| – | – |
|
3941
DiaMedica Therapeutics
DMAC
$364M
| $66.5K | ﹤0.01% |
24,000
-10,233
| -30% | -$29.7K |
|
|
RBOT
3942
DELISTED
Vicarious Surgical
RBOT
| $66.3K | ﹤0.01% |
7,328
+1,028
| +16% | +$12.3K |
|
3943
Urban One Class D
UONEK
$24.1M
| $64.3K | ﹤0.01% |
3,151
-489
| -13% | -$14.9K |
|
|
FSP
3944
Franklin Street Properties
FSP
$46.4M
| $61.6K | ﹤0.01% |
27,121
-32,415
| -54% | -$77.3K |
|
|
OPTU
3945
Optimum Communications Inc
OPTU
$228M
| $60.3K | ﹤0.01% |
23,100
-123,654
| -84% | -$311K |
|
|
3946
Urban One Class A
UONE
$23.5M
| $59K | ﹤0.01% |
2,186
| – | – |
|
3947
Stratasys
SSYS
$779M
| $58.3K | ﹤0.01% |
5,015
| – | – |
|
|
QVCGA
3948
DELISTED
QVC Group Inc Series A
QVCGA
| $57.3K | ﹤0.01% |
932
-6,485
| -87% | -$339K |
|
3949
LiveOne
LVO
$59.4M
| $57.3K | ﹤0.01% |
2,936
-1,733
| -37% | -$27.5K |
|
|
OKUR
3950
OnKure Therapeutics
OKUR
$158M
| $56.8K | ﹤0.01% |
3,423
-977
| -22% | -$16.1K |
|
Similar funds
Bank of New York Mellon's Q1 2024 Portfolio in Review
As of Q1 2024, Bank of New York Mellon held 4,422 positions worth $521B, up 5.6% from $493B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of New York Mellon withdrew a net $17.6B in Q1 2024, closing 270 positions and reducing 3,087 holdings. Its most notable exit was Splunk Inc, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Bank of New York Mellon opened a new position in Vanguard International Dividend Appreciation ETF worth $127M.
- Bank of New York Mellon's largest Q1 2024 buy was Vanguard International Dividend Appreciation ETF: 1,562,136 shares worth $127M.
- Bank of New York Mellon added most to ResMed in Q1 2024, an estimated $487M increase.
- Bank of New York Mellon's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $928M.
- Bank of New York Mellon fully exited Splunk Inc in Q1 2024, selling an estimated $143M.
- Bank of New York Mellon's ten largest holdings make up 22% of its $521B portfolio in Q1 2024.
- Bank of New York Mellon opened 113 new positions and closed 270 in Q1 2024.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $521B.
Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.